Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 12;13(10):1003.
doi: 10.3390/ijerph13101003.

The Impact of Secondhand Smoke Exposure on Children with Cystic Fibrosis: A Review

Affiliations
Review

The Impact of Secondhand Smoke Exposure on Children with Cystic Fibrosis: A Review

Benjamin T Kopp et al. Int J Environ Res Public Health. .

Abstract

Secondhand smoke exposure (SHSe) has multiple adverse effects on lung function and growth, nutrition, and immune function in children; it is increasingly being recognized as an important modifier of disease severity for children with chronic diseases such as cystic fibrosis (CF). This review examines what is known regarding the prevalence of SHSe in CF, with the majority of reviewed studies utilizing parental-reporting of SHSe without an objective biomarker of exposure. A wide range of SHSe is reported in children with CF, but under-reporting is common in studies involving both reported and measured SHSe. Additionally, the impact of SHSe on respiratory and nutritional health is discussed, with potential decreases in long-term lung function, linear growth, and weight gain noted in CF children with SHSe. Immunologic function in children with CF and SHSe remains unknown. The impact of SHSe on cystic fibrosis transmembrane conductance regulator (CFTR) function is also examined, as reduced CFTR function may be a pathophysiologic consequence of SHSe in CF and could modulate therapeutic interventions. Finally, potential interventions for ongoing SHSe are delineated along with recommended future areas of study.

Keywords: cystic fibrosis; pediatric; tobacco.

PubMed Disclaimer

Conflict of interest statement

The authors report no direct conflicts of interest.

References

    1. Bombieri C., Seia M., Castellani C. Genotypes and phenotypes in cystic fibrosis and cystic fibrosis transmembrane regulator-related disorders. Semin. Respir. Crit. Care Med. 2015;36:180–193. doi: 10.1055/s-0035-1547318. - DOI - PubMed
    1. Gibbs K., Collaco J.M., McGrath-Morrow S.A. Impact of tobacco smoke and nicotine exposure on lung development. Chest. 2016;149:552–561. doi: 10.1378/chest.15-1858. - DOI - PMC - PubMed
    1. Crotty Alexander L.E., Shin S., Hwang J.H. Inflammatory diseases of the lung induced by conventional cigarette smoke: A review. Chest. 2015;148:1307–1322. doi: 10.1378/chest.15-0409. - DOI - PubMed
    1. Ferrante G., Simoni M., Cibella F., Ferrara F., Liotta G., Malizia V., Corsello G., Viegi G., La Grutta S. Third-hand smoke exposure and health hazards in children. Monaldi Arch. Chest Dis. 2013;79:38–43. doi: 10.4081/monaldi.2013.108. - DOI - PubMed
    1. Mbulo L., Palipudi K.M., Andes L., Morton J., Bashir R., Fouad H., Ramanandraibe N., Caixeta R., Dias R.C., Wijnhoven T.M., et al. Secondhand smoke exposure at home among one billion children in 21 countries: Findings from the global adult tobacco survey (gats) Tob. Control. 2016 doi: 10.1136/tobaccocontrol-2015-052693. - DOI - PMC - PubMed

Substances